Outcome of Adolescents and Young Adults Compared to Pediatric Patients with Acute Myeloid and Promyelocytic Leukemia
Studies on outcome of adolescents and young adults (AYAs) with acute myeloid leukemia (AML) and acute promyelocytic leukemia (APL) are limited. We compared outcomes of AYAs (19-30 years) and pediatric (0-18 years) AML and APL patients using SEER-18 registry. AYAs with AML have worse early mortality and overall survival compared to pediatric AML, while AYAs and pediatric APL patients have similar outcomes.
Source: Clinical Lymphoma, Myeloma and Leukemia - Category: Hematology Authors: Syed Sameer Nasir, Smith Giri, Sara Nunnery, Mike G. Martin Tags: Original Study Source Type: research
More News: Acute Leukemia | Acute Myeloid Leukemia | Hematology | Leukemia | Lymphoma | Myeloma | Pediatrics | Study